SCHEMBL7704909

SCHEMBL7704909

CC1=C(N)Nc2cc(C(N)(Cc3ccccc3)C(=O)OC(C)(C)C)ccc2O1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.31
ALOX5 P09917 3/20 0.31
LTB4R Q15722 1/20 0.31
LTB4R2 Q9NPC1 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711363 0.93 EPHX2 (0.30)
SCHEMBL7708186 0.92
SCHEMBL7708351 0.90
SCHEMBL7704963 0.90 CYP3A4 (0.34)
SCHEMBL7704899 0.90 PKM (0.35) SMN1; SMN2
SCHEMBL7711245 0.90 LTB4R (0.33) LTB4RLTB4R2SMN1; SMN2
SCHEMBL7711358 0.89 ACE2 (0.34)
SCHEMBL7711326 0.89 GAA (0.30)
SCHEMBL7713432 0.88 PTPN1 (0.34)
SCHEMBL7708348 0.87 NR1D1 (0.35) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed